Equities

SkinBioTherapeutics PLC

SkinBioTherapeutics PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)14.00
  • Today's Change-0.625 / -4.27%
  • Shares traded776.79k
  • 1 Year change-41.05%
  • Beta2.5299
Data delayed at least 20 minutes, as of Nov 12 2024 15:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2023, cash reserves at SkinBioTherapeutics PLC fell by 493.09k. Cash Flow from Financing totalled 2.32m or 1,754.75% of revenues. In addition the company used 2.65m for operations while cash used for investing totalled 165.28k.
Cash flow per share-0.0161
Price/Cash flow per share--
Book value per share0.0192
Tangible book value per share0.0152
More ▼

Balance sheet in GBPView more

SkinBioTherapeutics PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio6.57
Quick ratio6.48
Total debt/total equity0.0266
Total debt/total capital0.0259
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.